The division’s commitment to research, in part funded through National Institutes of Health grants and conducted at the Advanced Liver Therapies Research Center at St. Luke’s Medical Center, gives patients access to the latest clinical trials, including those testing therapies for chronic viral hepatitis B and C infections and treatments for thrombocytopenia in liver disease.
Advanced Liver Therapies Research
Advanced Liver Therapies at St. Luke's is a clinical research center for liver diseases affiliated with the Baylor College of Medicine. The mission is to conduct clinical studies designed to advance the science and practice of hepatology and liver transplantation. We endorse and practice the highest standards of ethical research, while providing opportunities for all patients to participate in clinical trials.
Patients and referring physicians are highly satisfied and enrollment targets consistently meet or exceed with an average 249 percent enrollment. The St. Luke's Partnership for Liver Health allows the opportunity of educational outreach and screening events throughout Texas, 23 active patient support groups and provides over 40 percent of research patients.
St. Luke's Advanced Liver Therapies provides studies for a variety of liver diseases:
- Hepatitis C
- Hepatitis B
- Fatty Liver Disease
- Hepatic Encephalopathy
- Primary Biliary Cirrhosis
- Hepatorenal Syndrome
Find out more about Advanced Liver Therapies Research.